Roche Launches New SP116 Antibody to Aid in Prostate Cancer Diagnosis

Roche Launches New SP116 Antibody to Aid in Prostate Cancer Diagnosis
Roche says clinicians can now access its anti-p504 (SP116) antibody to help diagnose men with prostate cancer, representing a new way to detect the disease early using a simple laboratory assay. SP116, a monoclonal primary antibody, recognizes specific regions of a protein called α-methylacyl-CoA racemase (AMACR) — a useful biomarker in prostate adenocarcinoma due to its increased protein

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *